<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract"><front><journal-meta><journal-id journal-id-type="nlm-ta">Open Forum Infect Dis</journal-id><journal-id journal-id-type="iso-abbrev">Open Forum Infect Dis</journal-id><journal-id journal-id-type="publisher-id">ofid</journal-id><journal-title-group><journal-title>Open Forum Infectious Diseases</journal-title></journal-title-group><issn pub-type="epub">2328-8957</issn><publisher><publisher-name>Oxford University Press</publisher-name><publisher-loc>US</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">5631429</article-id><article-id pub-id-type="doi">10.1093/ofid/ofx180.006</article-id><article-id pub-id-type="publisher-id">ofx180.006</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstracts</subject><subj-group subj-group-type="category-toc-heading"><subject>Late Breaker Abstract</subject></subj-group></subj-group></article-categories><title-group><article-title>Prevention of Recurrent Acute Uncomplicated Cystitis by Increasing Daily Water in Premenopausal Women: A Prospective, Randomized, Controlled Study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hooton</surname><given-names>Thomas M</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="AF0001">1</xref></contrib><contrib contrib-type="author"><name><surname>Vecchio</surname><given-names>Mariacristina</given-names></name><degrees>PharmD</degrees><xref ref-type="aff" rid="AF0002">2</xref></contrib><contrib contrib-type="author"><name><surname>Iroz</surname><given-names>Alison</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="AF0002">2</xref></contrib><contrib contrib-type="author"><name><surname>Tack</surname><given-names>Ivan</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="AF0003">3</xref></contrib><contrib contrib-type="author"><name><surname>Dornic</surname><given-names>Quentin</given-names></name><degrees>MSc</degrees><xref ref-type="aff" rid="AF0002">2</xref></contrib><contrib contrib-type="author"><name><surname>Seksek</surname><given-names>Isabelle</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="AF0002">2</xref></contrib><contrib contrib-type="author"><name><surname>Lotan</surname><given-names>Yair</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="AF0004">4</xref></contrib></contrib-group><aff id="AF0001">
<label>1</label>
<institution>University of Miami Miller School of Medicine</institution>, <addr-line>Miami, Florida;</addr-line></aff><aff id="AF0002">
<label>2</label>
<institution>Danone Nutricia Research</institution>, <addr-line>Palaiseau</addr-line>, <country>France</country>;</aff><aff id="AF0003">
<label>3</label>
<institution>Clinical Physiology department, Medical School, Paul Sabatier University</institution>, <addr-line>Toulouse</addr-line>, <country>France</country>;</aff><aff id="AF0004">
<label>4</label>
<institution>University of Texas Southwestern Medical Center</institution>, <addr-line>Dallas, Texas</addr-line></aff><author-notes><fn id="fn-0001"><p>
<bold>Session:</bold> 228. Late Breaker Oral Abstracts</p><p>
<italic>Saturday, October 7, 2017: 10:30 AM</italic>
</p></fn></author-notes><pub-date pub-type="collection"><season>Fall</season><year>2017</year></pub-date><pub-date pub-type="epub" iso-8601-date="2017-10-04"><day>04</day><month>10</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>04</day><month>10</month><year>2017</year></pub-date><volume>4</volume><issue>Suppl 1</issue><issue-title>ID Week 2017 Abstracts</issue-title><fpage>S736</fpage><lpage>S736</lpage><permissions><copyright-statement>© The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America.</copyright-statement><copyright-year>2017</copyright-year><license license-type="cc-by-nc-nd" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com</license-p></license></permissions><self-uri xlink:href="ofx180.006.pdf"></self-uri><abstract><title><offsets xml_i="4710" xml_f="4718" txt_i="11" txt_f="19">Abstract</offsets></title><sec id="s1"><title><offsets xml_i="4746" xml_f="4756" txt_i="20" txt_f="30">Background</offsets></title><p><offsets xml_i="4767" xml_f="5058" txt_i="31" txt_f="322">Increased hydration is commonly recommended as a preventive measure for women with recurrent acute uncomplicated cystitis (rAUC), but supportive data are sparse. The aim of this study was to assess the efficacy of increased daily water intake on the frequency of rAUC in premenopausal women.</offsets></p></sec><sec id="s2"><title><offsets xml_i="5088" xml_f="5095" txt_i="324" txt_f="331">Methods</offsets></title><p><offsets xml_i="5106" xml_f="5233" txt_i="332" txt_f="459">140 healthy premenopausal asymptomatic women drinking less than 1.5 L of total fluid daily (24 hours) and suffering from rAUC (</offsets><sup><offsets xml_i="5238" xml_f="5239" txt_i="459" txt_f="460">3</offsets></sup><offsets xml_i="5245" xml_f="5788" txt_i="460" txt_f="1003">3 episodes in the past year) were randomized to receive, in addition to their usual daily fluid intake, either 1.5 L water daily (water group) or no additional fluids (control group), for 12 months. Assessments of daily water and total fluid intake, urine volume and osmolality, number of urine voids, and occurrence of AUC symptoms and a reminder to notify investigators of any such symptoms were performed at baseline, 6- and 12-month clinic visits in addition to monthly telephone calls. The primary outcome was frequency of rAUC episodes (</offsets><sup><offsets xml_i="5793" xml_f="5794" txt_i="1003" txt_f="1004">3</offsets></sup><offsets xml_i="5800" xml_f="5818" txt_i="1004" txt_f="1022">1 AUC symptom and </offsets><sup><offsets xml_i="5823" xml_f="5824" txt_i="1022" txt_f="1023">3</offsets></sup><offsets xml_i="5830" xml_f="5832" txt_i="1023" txt_f="1025">10</offsets><sup><offsets xml_i="5837" xml_f="5838" txt_i="1025" txt_f="1026">3</offsets></sup><offsets xml_i="5844" xml_f="5901" txt_i="1026" txt_f="1083"> CFU/mL of a uropathogen in voided urine) over 12 months.</offsets></p></sec><sec id="s3"><title><offsets xml_i="5931" xml_f="5938" txt_i="1085" txt_f="1092">Results</offsets></title><p><offsets xml_i="5949" xml_f="6451" txt_i="1093" txt_f="1595">Between baseline and 12 month’s follow-up, the water group, compared with the control group, had statistically significant increases in mean daily water intake (1.15 vs. −0.01 L), total fluid intake (1.65 vs. 0.03 L), urine volume (1.40 vs. 0.04 L), and number of urine voids (2.2 vs. −0.2), and a decrease in urine osmolality (−408 vs. −35 mOsm/Kg). The mean number of rAUC episodes in the water group was significantly less than in the control group (1.6 vs. 3.1; odds ratio 0.52, 95% CI 0.46–0.60,  </offsets><italic><offsets xml_i="6459" xml_f="6465" txt_i="1595" txt_f="1598">P &lt;</offsets></italic><offsets xml_i="6474" xml_f="6690" txt_i="1598" txt_f="1814"> 0.0001) (figure shows cumulative sum of AUC episodes over 12 months in both study groups). The mean number of antimicrobial regimens used to treat AUC events was 1.8 in the water group vs. 3.5 in the control group (</offsets><italic><offsets xml_i="6698" xml_f="6704" txt_i="1814" txt_f="1817">P &lt;</offsets></italic><offsets xml_i="6713" xml_f="6900" txt_i="1817" txt_f="2004"> 0.0001). In addition, the mean number of days to first rAUC and the mean number of days between rAUC episodes was longer in the water group compared with the control group (148 vs. 93,  </offsets><italic><offsets xml_i="6908" xml_f="6911" txt_i="2004" txt_f="2007">P =</offsets></italic><offsets xml_i="6920" xml_f="6944" txt_i="2007" txt_f="2031"> 0.0005 and 143 vs. 85, </offsets><italic><offsets xml_i="6952" xml_f="6958" txt_i="2031" txt_f="2034">P &lt;</offsets></italic><offsets xml_i="6967" xml_f="6990" txt_i="2034" txt_f="2057"> 0.0001, respectively).</offsets></p><fig fig-type="figure" id="F1" orientation="portrait" position="float"><graphic xlink:href="OFIDIS_ofx180_IF004"></graphic></fig></sec><sec id="s4"><title><offsets xml_i="7149" xml_f="7160" txt_i="2059" txt_f="2070">Conclusions</offsets></title><p><offsets xml_i="7171" xml_f="7445" txt_i="2071" txt_f="2345">Our results provide strong evidence that increased water intake is an effective antimicrobial-sparing preventive strategy for women with rAUC. Increasing daily water intake by approximately 1.5 L reduced rAUC episodes by 48% and antimicrobial regimens by 47% over 12 months.</offsets></p></sec><sec id="s5"><title><offsets xml_i="7475" xml_f="7486" txt_i="2347" txt_f="2358">Disclosures</offsets></title><p><offsets xml_i="7497" xml_f="7498" txt_i="2359" txt_f="2360">
</offsets><bold><offsets xml_i="7504" xml_f="7514" txt_i="2360" txt_f="2370">M. Vecchio</offsets></bold><offsets xml_i="7521" xml_f="7558" txt_i="2370" txt_f="2407">, Danone Research: Employee, Salary. </offsets><bold><offsets xml_i="7564" xml_f="7571" txt_i="2407" txt_f="2414">A. Iroz</offsets></bold><offsets xml_i="7578" xml_f="7616" txt_i="2414" txt_f="2452">, Dzanone Research: Employee, Salary. </offsets><bold><offsets xml_i="7622" xml_f="7629" txt_i="2452" txt_f="2459">I. Tack</offsets></bold><offsets xml_i="7636" xml_f="7706" txt_i="2459" txt_f="2529">, Danone Research: Consultant, Consulting fee and Speaker honorarium. </offsets><bold><offsets xml_i="7712" xml_f="7721" txt_i="2529" txt_f="2538">Q. Dornic</offsets></bold><offsets xml_i="7728" xml_f="7765" txt_i="2538" txt_f="2575">, Danone research: Employee, Salary. </offsets><bold><offsets xml_i="7771" xml_f="7780" txt_i="2575" txt_f="2584">I. Seksek</offsets></bold><offsets xml_i="7787" xml_f="7823" txt_i="2584" txt_f="2620">, Danone Research: Employee, Salary.</offsets></p></sec></abstract><counts><page-count count="1"></page-count></counts></article-meta></front></article>